Oct. 24 at 9:39 PM
$LXRX Short interest for the 1H of October is out after close today and shows a drop of 466k or 1.7% leaving over 26.8 million shares short.
LXRX shares closed at
$1.35 on Sept 30th and at
$1.53 on October 15, 2025.
These next two weeks may not bring news but I wonder if the shorts have been adding since it was taken down for options expiration. And, other than one larger up day, LXRX has been mostly range bound here in the lower
$1.4x range.
When we do have the earnings report and conference call, we may get some updates on earnings the next
$39 million milestone from Novo (turn over IND data/info but Novo to file the IND with FDA), perhaps a reasonable earnings report since they did not recognize the full
$45 million 2Q (but most of it) and then word on Inpefa trials for HCM and partnership programs for Pilavapadin.
I still don’t know what the shorts are waiting on to cover as this was
$0.40 in March.
From: https://www.nasdaq.com/market-activity/stocks/lxrx/short-interest